Identification of Flavonoid-based Hypoxia-inducible Factor-2 Alpha Inhibitors for the Treatment of Breast Cancer– In silico and In vitro Evidence
Morin demonstrated promising anti-cancer activity under hypoxic conditions by inhibiting HIF-2α in the hypoxia signaling pathway.
Authors
- Habeeb Shaik Mohideen
- Mursaleen Baba
- Satish Ramalingam (ORCID: https://orcid.org/0000-0002-3076-279X)
- Ravi Gor (ORCID: https://orcid.org/0000-0002-3208-8209)
- C. Ramamurthy
- Thangavel Mahalingam Vijayakumar
- Shahinaz
Institutions
- SRM Institute of Science and Technology (IN)
- University of Oklahoma Health Sciences Center (US)
Publication Details
- Journal
- Anti-Cancer Agents in Medicinal Chemistry
- Published
- 2025-04-25
- DOI
- https://doi.org/10.2174/0118715206377378250414052656
- Citations
- 1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94